Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches

• Autors principals: Rodrigo L. Castillo (Autor), Mauricio Ibacache (Autor), Ignacio Cortínez (Autor), Catalina Carrasco-Pozo (Autor), Jorge G. Farías (Autor), Rodrigo A. Carrasco (Autor), Patricio Vargas-Errázuriz (Autor), Daniel Ramos (Autor), Rafael Benavente (Autor), Daniela Henríquez Torres (Autor), Aníbal Méndez (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Dexmedetomidine (DEX) is a highly selective α2-adrenergic agonist with sedative and analgesic properties, with minimal respiratory effects. It is used as a sedative in the intensive care unit and the operating room. The opioid-sparing effect and the absence of respiratory effects make dexmedetomidin...